Glucocorticoid receptor-mineralocorticoid receptor heterodimer interface (GR-MR heterodimer interface) (GR-MR heterodimer interface)

The Glucocorticoid receptor-mineralocorticoid receptor (GR-MR) heterodimer interface is a specialized protein-protein interaction site where the glucocorticoid receptor (GR; NR3C1) and the mineralocorticoid receptor (MR; NR3C2) associate to form a functional transcription factor complex [1.2.1, 1.3.3]. This heterodimerization occurs in tissues where both receptors are co-expressed, notably the hippocampus, kidney, and skin, and it provides a mechanism for generating diverse transcriptional responses to corticosteroids [1.3.2, 1.5.1]. The interface involves specific regions within the ligand-binding domain (LBD) and the DNA-binding domain (DBD), and its stability is influenced by the specific ligands bound to the receptors [1.1.1, 1.2.1]. Research indicates that the GR-MR heterodimer plays a central role in the physiological stress response and behavioral adaptation, with imbalances in this signaling pathway linked to neuropsychiatric disorders such as depression and anxiety [1.4.2, 1.5.3]. Furthermore, the heterodimer is a relevant target in oncology, specifically in multiple myeloma, where GR-MR crosstalk can be modulated to enhance the efficacy of glucocorticoid-based therapies [1.4.3]. Various therapeutic glucocorticoids, including dexamethasone and prednisolone, induce heterodimer formation to varying degrees, suggesting that the interface could be targeted to fine-tune therapeutic outcomes and reduce systemic side effects [1.1.1]. Selective modulation of this interface represents a novel pharmacological approach to achieve tissue-specific or pathway-specific corticosteroid effects while minimizing the adverse metabolic and psychiatric effects associated with traditional steroid treatments [1.1.1, 1.3.1].

Other names

GR-MR complexMR-GR heterodimerNR3C1-NR3C2 heterodimer interfaceCorticosteroid receptor heterodimer

Ligand-induced heterodimerization of GR and MR leading to differential binding at glucocorticoid response elements (GREs) and distinct transcriptional regulation compared to homodimeric forms.